What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
His primary areas of investigation include Immunology, Internal medicine, Autoimmunity, Vitamin D and neurology and Rheumatoid arthritis.
Autoantibody, Antibody, Autoimmune disease, Immune system and Lupus erythematosus are among the areas of Immunology where he concentrates his study.
He interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine.
The Autoimmunity study combines topics in areas such as Viral immunology, Mosaic and Virology.
His Vitamin D and neurology study integrates concerns from other disciplines, such as Proinflammatory cytokine, Multiple sclerosis, Vitamin and Antiphospholipid syndrome.
Howard Amital combines subjects such as Inflammation, Epidemiology, Retrospective cohort study and Hazard ratio with his study of Rheumatoid arthritis.
His most cited work include:
- Effects of tobacco smoke on immunity, inflammation and autoimmunity (591 citations)
- Effects of tobacco smoke on immunity, inflammation and autoimmunity (591 citations)
- Vitamin D and autoimmunity: new aetiological and therapeutic considerations (473 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Immunology, Rheumatoid arthritis, Disease and Autoimmunity.
His work on Internal medicine is being expanded to include thematically relevant topics such as Gastroenterology.
His study in Vitamin D and neurology extends to Immunology with its themes.
His work deals with themes such as Physical therapy, Methotrexate and Arthritis, which intersect with Rheumatoid arthritis.
His study brings together the fields of Multiple sclerosis and Autoimmunity.
His Univariate analysis research includes elements of Cross-sectional study and Comorbidity.
He most often published in these fields:
- Internal medicine (78.34%)
- Immunology (45.75%)
- Rheumatoid arthritis (24.78%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (78.34%)
- Immunology (45.75%)
- Disease (22.53%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Immunology, Disease, Autoimmunity and Retrospective cohort study.
His Immunology research focuses on Immune system, Autoantibody, Antibody, Experimental autoimmune encephalomyelitis and Inflammation.
He has researched Disease in several fields, including MHC class I and Risk factor.
The study incorporates disciplines such as Diabetes mellitus, Significant difference, Single Center and Giant cell arteritis in addition to Retrospective cohort study.
His Logistic regression research includes themes of Case-control study, Polymyositis, Dermatomyositis, Rheumatoid arthritis and Rheumatology.
His research integrates issues of Autoimmune disease and Population study in his study of Univariate analysis.
Between 2018 and 2021, his most popular works were:
- Covid-19 and autoimmunity. (81 citations)
- Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis. (39 citations)
- Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis. (39 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Howard Amital mostly deals with Internal medicine, Retrospective cohort study, Autoimmunity, Disease and Cohort study.
His research on Internal medicine often connects related topics like Gastroenterology.
His Retrospective cohort study study combines topics from a wide range of disciplines, such as Diabetes mellitus, Mortality rate, SOFA score, Intensive care unit and Single Center.
His study with Autoimmunity involves better knowledge in Immunology.
His biological study deals with issues like Univariate analysis, which deal with fields such as Distress, Epidemiology, Logistic regression and Weight loss.
His Adalimumab study, which is part of a larger body of work in Rheumatoid arthritis, is frequently linked to Sarilumab, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
